VEGA MARKET FLASH: التحقيق الأمريكي بشأن الإجراءات التعويضية التجارية (CVD) على منتجات L-Lysine الواردة من الصين
On January 20, 2026, the U.S. Department of Commerce (DOC) announced its preliminary countervailing duty (CVD) determination concerning imports of L-lysine from China, following a ruling issued on January 16, 2026. The investigation examines whether Chinese producers have benefited from government subsidies that unfairly impact the U.S. market.
Preliminary Subsidy Rates
According to the DOC’s preliminary findings:
Heilongjiang Wanlirunda Biotechnology Co., Ltd.
Shouguang Golden-land Industry & Trading Co., Ltd.
have been assigned a countervailing duty rate of 80.37%.
Meanwhile,
Inner Mongolia Eppen Biotech Co., Ltd.
All other Chinese producers/exporters
are subject to a subsidy rate of 39.50%.
The products under investigation are primarily classified under U.S. HS code 2922.41.0090, covering L-lysine and related forms.
Investigation Timeline
The anti-dumping (AD) and countervailing duty (CVD) investigations were formally initiated on June 18, 2025. The U.S. Department of Commerce is expected to issue its final CVD determination on May 18, 2026, which will confirm whether the provisional rates will be adjusted or made permanent.
Market Implications
L-lysine is a key amino acid widely used in animal nutrition, particularly in poultry and swine feed formulations. The preliminary CVD ruling may have notable implications for global lysine trade flows, including:
Changes in export competitiveness for Chinese producers
Potential price volatility in the U.S. and global markets
Increased attention to supply chain diversification among feed manufacturers and traders
Market participants are advised to closely monitor the progress of the investigation, as the final determination could further influence procurement strategies and long-term sourcing decisions.
As trade remedy measures continue to shape the international feed additives market, regulatory developments such as this CVD case highlight the importance of regulatory compliance, risk management, and market transparency across the global supply chain. Further updates will follow as the investigation moves toward its final determination.
